Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon-Reference-Cited by-同舟云学术

Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon

Published:2017-06-21 Issue:6 Volume:12 Page:e0179400
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Mascia Claudia,Vita Serena,Zuccalà Paola,Marocco Raffaella,Tieghi Tiziana,Savinelli Stefano,Rossi Raffaella,Iannetta Marco,Pozzetto Irene,Furlan Caterina,Mengoni Fabio,Mastroianni Claudio Maria,Vullo Vincenzo,Lichtner Miriam

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. Pathogenesis, natural history, treatment, and prevention of hepatitis C;TJ Liang;Ann Intern Med,2000

2. First-generation protease inhibitor-triple therapy: SVR 24, safety, and predictors of response in a large single center cohort;CR Werner;Virol J,2015

3. The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment;BP Lam;Therap Adv Gastroenterol,2015

4. Interferon γ-induced protein 10 kinetics in treatment-naive versus treatment-experienced patients receiving interferon-free therapy for hepatitis C virus infection: implications for the innate immune response;JC Lin;J Infect Dis,2014

5. IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease;AA Negash;PLoS Pathog,2013

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Injecting drug use and hepatitis C virus infection independently increase biomarkers of inflammatory disease risk which are incompletely restored by curative direct-acting antiviral therapy;Frontiers in Immunology;2024-02-14

2. Imprinted immune abnormalities in liver transplant patients cured of hepatitis C with antiviral drugs;Liver Transplantation;2024-02-06

3. Immune Biomarker Changes in HIV/HCV-Coinfected Individuals After Direct-Acting Antiviral Treatment: A Prospective Study in Indonesia;2024

4. Steroid use in measles: A retrospective cohort study during the 2017 outbreak in tertiary referral center, Rome and Latina, Italy;Journal of Infection and Chemotherapy;2023-10

5. Gender-Specific Differences in Serum Sphingomyelin Species in Patients with Hepatitis C Virus Infection—Sphingomyelin Species Are Related to the Model of End-Stage Liver Disease (MELD) Score in Male Patients;International Journal of Molecular Sciences;2023-05-07